Bone health in cancer: ESMO Clinical Practice Guidelines

被引:289
|
作者
Coleman, R. [1 ]
Hadji, P. [2 ,3 ]
Body, J-J [4 ]
Santini, D. [5 ]
Chow, E. [6 ]
Terpos, E. [7 ]
Oudard, S. [8 ]
Bruland, O. [9 ,10 ]
Flamen, P. [11 ]
Kurth, A. [12 ,13 ]
Van Poznak, C. [14 ]
Aapro, M. [15 ]
Jordan, K. [16 ]
机构
[1] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England
[2] Frankfurt Ctr Bone Hlth, Frankfurt, Germany
[3] Philipps Univ Marburg, Marburg, Germany
[4] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium
[5] Univ Campus Biomed, Med Oncol Dept, Rome, Italy
[6] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[7] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[8] Paris Descartes Univ, Georges Pompidou Hosp, Dept Med Oncol, Paris, France
[9] Univ Oslo, Inst Clin Med, Oslo, Norway
[10] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway
[11] Univ Libre Bruxelles, Inst Jules Bordet, Dept Nucl Med, Brussels, Belgium
[12] Community Clin Middle Rhine, Dept Orthopaed & Trauma Surg, Campus Kemperhof, Koblenz, Germany
[13] Univ Med Mainz, Major Teaching Hosp, Mainz, Germany
[14] Univ Michigan, Ann Arbor, MI 48109 USA
[15] Genolier Canc Ctr, Genolier, Switzerland
[16] Heidelberg Univ, Dept Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany
关键词
bone metastases; cancer treatment-induced bone loss; bone-targeted agents; Clinical Practice Guidelines; diagnosis; treatment; follow-up; EARLY BREAST-CANCER; ZOLEDRONIC ACID; MULTIPLE-MYELOMA; DOUBLE-BLIND; SOLID TUMORS; OPEN-LABEL; DENOSUMAB; METASTASES; PHASE-3; SURVIVAL;
D O I
10.1016/j.annonc.2020.07.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1650 / 1663
页数:14
相关论文
共 50 条
  • [41] Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Colombo, N.
    Preti, E.
    Landoni, F.
    Carinelli, S.
    Colombo, A.
    Marini, C.
    Sessa, C.
    ANNALS OF ONCOLOGY, 2011, 22 : vi35 - vi39
  • [42] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Pacini, F.
    Castagna, M. G.
    Brilli, L.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2010, 21 : v214 - v219
  • [43] Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Stahl, M.
    Mariette, C.
    Haustermans, K.
    Cervantes, A.
    Arnold, D.
    ANNALS OF ONCOLOGY, 2013, 24 : 51 - 56
  • [44] Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
    Ducreux, M.
    Cuhna, A. Sa.
    Caramella, C.
    Hollebecque, A.
    Burtin, P.
    Goere, D.
    Seufferlein, T.
    Haustermans, K.
    Van Laethem, J. L.
    Conroy, T.
    Arnold, D.
    ANNALS OF ONCOLOGY, 2015, 26 : V56 - V68
  • [45] Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Horwich, A.
    Parker, C.
    Bangma, C.
    Kataja, V.
    ANNALS OF ONCOLOGY, 2010, 21 : v129 - v133
  • [46] Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Glynne-Jones, R.
    Wyrwicz, L.
    Tiret, E.
    Brown, G.
    Rodel, C.
    Cervantes, A.
    Arnold, D.
    ANNALS OF ONCOLOGY, 2017, 28 : 22 - 40
  • [47] Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Colombo, N.
    Preti, E.
    Landoni, F.
    Carinelli, S.
    Colombo, A.
    Marini, C.
    Sessa, C.
    ANNALS OF ONCOLOGY, 2013, 24 : 33 - 38
  • [48] Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Parker, C.
    Castro, E.
    Fizazi, K.
    Heidenreich, A.
    Ost, P.
    Procopio, G.
    Tombal, B.
    Gillessen, S.
    ANNALS OF ONCOLOGY, 2020, 31 (09) : 1119 - 1134
  • [49] Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Glimelius, B.
    Tiret, E.
    Cervantes, A.
    Arnold, D.
    ANNALS OF ONCOLOGY, 2013, 24 : 81 - 88
  • [50] Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Eckel, F.
    Brunner, T.
    Jelic, S.
    ANNALS OF ONCOLOGY, 2011, 22 : vi40 - vi44